Planning and performing observational and interventional studies and registries are some of our main activities. Our research methodological expertise is also actively involved in implementing innovative study’s designs and research methods, especially for rare and paediatric diseases.

We work on the Health Technology Assessment (HTA), to evaluate both real and potential effects of technology, as well as the consequences that the introduction or the exclusion of an intervention (for example a medicine or a device) has for the health system, the economy and society. The activity includes the conduct of studies and analysis aimed at providing summaries and evaluations of the available evidence, including Patient Reported Outcomes (PROs) and Quality of Life (QoL) assessment.

.